Konferenzen  >  Medizin & Gesundheitswesen  >  Onkologie  >  Vereinigte Staaten

Binaytara Foundation

This CME-accredited oncology conference, BTF's 2024 Updates on Hematology and Oncology, Fresno, is designed to improve the care of cancer patients by educating clinicians involved in cancer care. The expert faculty will present a comprehensive overview of recent updates in hematology and oncology, and practice-changing abstracts from the 2024 American Society of Clinical Oncology Annual Meeting (ASCO2024) held in June 2024. The program will feature in-depth discussions and analyses of the latest scientific discoveries and advancements. Faculty will contextualize these findings within clinical practice and explore their potential to alter current standards of care. This conference is designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals, providing them with the latest updates in the field. Emphasizing a multidisciplinary approach, it will showcase the integration of new advancements into patient-centered care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

CHI

In the past 11 years, CHI’s Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.

Tel.: [781.972.5400];     Email: chi@healthtech.com

In the past 11 years, CHI's Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.

Binaytara Foundation

The Southwest Hematology Oncology Conference: Precision Guided Therapy is a 1-day educational and scientific meeting that will focus on the updates in the biomarker-guided management of patients with common malignancies. This conference will feature experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. In addition, expert faculty will place key abstract findings from the 2024 ASCO Annual Meeting into a clinical context and discuss how the results may change the current standards of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to incorporate biomarker-guided therapy in the management of patients with cancer.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology, Precision Guided Therapy, Malignancies

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Binaytara Foundation

This CME-accredited activity, “2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility” features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. The faculty will discuss barriers to using cellular therapy and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Accessibility, Lymphoma, Myeloma, Acute Leukemia

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Binaytara Foundation

This CME-accredited activity, Wisconsin Multiple Myeloma & Lymphoma Summit, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology, Myeloma, Lymphoma

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

CHI

The Next Generation Dx Summit, taking place at the Capital Hilton in Washington, D.C., on August 19-21, 2024, is the must-attend event for diagnostics advancements, as well as the nexus for international thought leaders to discuss diagnostic and technology innovation. This year’s event provides a valuable window on the state-of-the-art forecasting and future trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. This must-attend Summit offers incomparable networking and complete coverage of the most timely and important topics for the industry.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Binaytara Foundation

The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Breast Cancer, Gynecologic Malignancies, Oncology

Fortbildung für Gesundheitsfachberufe (CME),    Gynäkologie/Geburtshilfe

Binaytara Foundation

This CME-accredited activity Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice features leading experts in hematologic malignancies and cellular therapies who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Lymphoma, Myeloma, Acute Leukemia

Fortbildung für Gesundheitsfachberufe (CME),    Hämatologie

Binaytara Foundation

This CME-accredited activity, Park City Lymphoma Myeloma Conference, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Hematology, Lymphoma, Myeloma, Waldenström Macroglobulinemia

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Binaytara Foundation

The 4th Binaytara Precision Oncology Summit is a 2-day CME-accredited conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology. The theme for this year's summit, "Current Standards and Emerging Therapies," highlights the conference's commitment to providing a comprehensive overview of the field, including in-depth discussions on the latest developments in precision oncology, alongside a thorough examination of established treatment protocols. Focus on actionable mutations ensures that the presented information translates directly into improved patient care. The summit features didactics, panel discussions, interactive case studies, and scientific abstract presentations.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

cancer, oncology, CME, continuing medical education

Binaytara Foundation

This accredited continuing education activity, the Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Precision Oncology, Hematology, Malignancies, Continuing Medical Education (CME)

Binaytara Foundation

This CME-accredited activity, the 2024 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC). The primary aim of this conference is to enhance the knowledge and competence of participants, enabling them to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for lung cancer patients. The program includes detailed discussions and analyses of the latest scientific discoveries and advancements in molecular testing and targeted therapies for thoracic oncology. The expert faculty will focus on the clinical application of diagnostics, biomarkers, and various therapeutic agents, discussing how these tests and treatments can be effectively used to improve patient care.

Tel.: [425-616-0572];     Email: hanna.k@binayfoundation.org

Lung Cancer, Oncology, NSCLC, SCLC, CME, Continuing Medical Education

Infonet

4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia, USA during March 06- 08, 2025. iCancer Conference 2025 has a theme "Innovations in Cancer Research".

Tel.: [06172752612];     Email: jessie@icancerconference.org

Keywords: Conference, Cancer, oncology, Oncology - Medical, oncology meetings, Cancer Conference, Philadelphia, Breast cancer conference Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy,